Shares of Pacific Biosciences of California slid by a staggering 20.87% in 14 days from $8.84 to $29.71 at 10:28 EST on Tuesday, following last session’s downward trend. NASDAQ Composite is sliding 0.18% to $13,889.38, following last session’s downward trend, This seems, as yet, a somewhat rough trend exchanging session today.

Pacific Biosciences of California’s last close was $31.53, 80.71% below its 52-week high of $53.69.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 64.6% for the current quarter and 73.4% for the next. The company’s growth estimates for the present quarter and the next is a negative 4600% and a negative 20%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth declined by 2.8%, now sitting on 78.89M for the twelve trailing months.

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $29.71 at 10:28 EST, way below its 52-week high of $53.69 and way higher than its 52-week low of $2.66.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s worth is way below its 50-day moving average of $33.94 and way higher than its 200-day moving average of $24.72.

More news about Pacific Biosciences of California.

LEAVE A REPLY

Please enter your comment!
Please enter your name here